Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
gene editing
12
×
crispr
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
medicine
science
boston
boulder/denver blog main
boulder/denver top stories
crispr-cas9
detroit blog main
detroit top stories
dna
editas medicine
fda
glaxosmithkline
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
tomorrow
wisconsin blog main
wisconsin top stories
base editing
celgene
clinical study
clinical trials
What
crispr
12
×
editing
gene
new
bio
cas
medicine
editas
roundup
trial
used
years
ceo
genetic
hiv
humans
katrine
medical
million
researchers
scientists
therapeutics
tool
university
allergan
allogene
approach
areas
authorities
authorization
babies
beam
big
biopharma
blessing
body
bosley
bosley's
bosley’s
bridge
Language
unset
Current search:
crispr
×
" gene editing "
×
@engadget.com
3 years ago
CRISPR gene editing pioneers win the 2020 Nobel Prize in Chemistry
@extremetech.com
4 years ago
Chinese Scientist Responsible for Genetically Engineered Babies Gets 3 Years in Prison
@digitaltrends.com
4 years ago
CRISPR-Cas9 gene editing could one day ‘turn off’ HIV virus in the body
@engadget.com
5 years ago
Scientists created a CRISPR tool that can wipe out longer pieces of DNA
@engadget.com
5 years ago
CRISPR gene editing has been used on humans in the US
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@extremetech.com
5 years ago
CRISPR Gene Editing May Have Unanticipated Side Effects
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M